Are major health insurers actively trying to discourage older adults from signing up for Medicare plans? It sounds shocking, but that's precisely what's happening, and the reason might surprise you: profit. Major players in the health insurance industry, including Humana and UnitedHealth, are making moves that are raising eyebrows and drawing criticism from insurance brokers and even state regulators.
Bob Herman, Business of Health Care Reporter, reveals that these large insurers, along with Anthem, Centene, and regional players like SummaCare, are either slashing or completely eliminating the commissions they pay to brokers for enrolling people in Medicare plans. But here's where it gets controversial... Some companies are even cutting off broker access to online enrollment portals altogether. These decisions, according to company notices obtained by STAT, largely occurred right after October 15th, the start of Medicare's annual enrollment period, which runs until December 7th. Could this timing be a coincidence? You be the judge.
So, why the sudden change of heart? Well, it's all about the bottom line. Insurers are scrambling to boost profits and adapt to the changes brought about by the Inflation Reduction Act. They've been busy overhauling their 2026 Medicare Advantage and Medicare prescription drug plans. And this is the part most people miss... It's not just about profits; it's about managing risk. An estimated 3 million people are facing the termination of their current Medicare Advantage plans and are forced to choose new coverage.
Over the past few years, the Medicare market has become a high-stakes game of 'hot potato.' Companies like Humana, CVS Health's Aetna, and UnitedHealthcare have been strategically tweaking their benefits and drug formularies, with the underlying intention of pushing their sicker, more expensive customers toward competitor plans. Think of it like this: they're trying to offload the financial burden of caring for individuals with significant health needs onto other insurers. This could involve, for example, reducing coverage for a particular medication that many of their high-cost patients rely on, making their plan less attractive to those individuals. Do you think this is a fair business practice, or is it putting profits ahead of patient care?
This raises some serious questions: Is it ethical for insurers to actively discourage enrollment to improve their financial standing? Are these actions ultimately harming seniors who rely on brokers for guidance in navigating the complex world of Medicare? And what role should state regulators play in overseeing these practices? Share your thoughts in the comments below – we'd love to hear your perspective.
